Fludeoxyglucose (18F) Recruiting Phase 4 Trials for Type 1 Diabetes Mellitus Other

IndicationsStatusPurposePhase
RecruitingOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT05641753Cholesterol Lowering and Residual Risk in Diabetes, Type 1